GENELABS TECHNOLOGIES INC /CA
S-3/A, EX-23.1, 2000-05-30
PHARMACEUTICAL PREPARATIONS
Previous: GENELABS TECHNOLOGIES INC /CA, S-3/A, 2000-05-30
Next: ALKERMES INC, 424B3, 2000-05-30



<PAGE>   1
                                                                    EXHIBIT 23.1

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in
Amendement No. 1 to the Registration Statement (Form S-3 No. 333-34630) and
related Prospectus of Genelabs Technologies, Inc. for the registration of
5,000,000 shares of its common stock and to the incorporation by reference
therein of our report dated February 10, 2000 with respect to the consolidated
financial statements of Genelabs Technologies, Inc. included in its Annual
Report on Form 10-K for the year ended December 31, 1999, filed with the
Securities and Exchange Commission.

                                        /s/ ERNST & YOUNG LLP

Palo Alto, California
May 26, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission